Become a Creator today!Start creating today - Share your story with the world!
Start for free
00:00:00
00:00:01
Ep#036: Tackling Sepsis Using Next Generation Sequencing with Dr. Philip Stevens
92 Plays2 years ago
Welcome to Season 3 of the Personalized Medicine Podcast! We hope you all head a good start in 2022 and are ready to dive deep into the world of personalized medicine with us again.
In this first episode of Season 3, we address a very important and, frankly speaking, underappreciated topic of sepsis, commonly known as bacterial blood poisoning. Did you know that last year, sepsis killed more people than 5 most common types of cancer combined?
For this episode, our host Oleksandr Yagensky sat down with the co-founder and CEO of Noscendo, Dr. Philip Stevens. Philip and his team are developing diagnostic workflows based on detection of bacterial and fungal cell-free DNA from blood to detect infections.
Listen to this episode to learn more about:
◦ The founding story of Noscendo
◦ Building a successful diagnostics startup in Europe
◦ Generation of clinical evidence for early stage startups
◦ Misconceptions about sepsis and sepsis diagnostics
◦ How NGS can help detect sepsis early
◦ Role of DNA sequencing in determining antibiotic resistance
◦ Philip’s advice to aspiring life science entrepreneurs
Get in touch with Philip:
◦ LinkedIn: https://www.linkedin.com/in/philip-stevens-4ab68213b/
◦ Twitter: https://twitter.com/noscendo
◦ Web: https://noscendo.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
In this first episode of Season 3, we address a very important and, frankly speaking, underappreciated topic of sepsis, commonly known as bacterial blood poisoning. Did you know that last year, sepsis killed more people than 5 most common types of cancer combined?
For this episode, our host Oleksandr Yagensky sat down with the co-founder and CEO of Noscendo, Dr. Philip Stevens. Philip and his team are developing diagnostic workflows based on detection of bacterial and fungal cell-free DNA from blood to detect infections.
Listen to this episode to learn more about:
◦ The founding story of Noscendo
◦ Building a successful diagnostics startup in Europe
◦ Generation of clinical evidence for early stage startups
◦ Misconceptions about sepsis and sepsis diagnostics
◦ How NGS can help detect sepsis early
◦ Role of DNA sequencing in determining antibiotic resistance
◦ Philip’s advice to aspiring life science entrepreneurs
Get in touch with Philip:
◦ LinkedIn: https://www.linkedin.com/in/philip-stevens-4ab68213b/
◦ Twitter: https://twitter.com/noscendo
◦ Web: https://noscendo.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
Recommended
